PL3322480T3 - Bakterie Lactobacillus w leczeniu zaburzeń czynności serca - Google Patents

Bakterie Lactobacillus w leczeniu zaburzeń czynności serca

Info

Publication number
PL3322480T3
PL3322480T3 PL16736860T PL16736860T PL3322480T3 PL 3322480 T3 PL3322480 T3 PL 3322480T3 PL 16736860 T PL16736860 T PL 16736860T PL 16736860 T PL16736860 T PL 16736860T PL 3322480 T3 PL3322480 T3 PL 3322480T3
Authority
PL
Poland
Prior art keywords
treatment
cardiac dysfunction
lactobacillus bacteria
lactobacillus
bacteria
Prior art date
Application number
PL16736860T
Other languages
English (en)
Inventor
Lotta STENMAN
Sampo Lahtinen
John KONHILAS
Original Assignee
Dupont Nutrition Biosciences Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dupont Nutrition Biosciences Aps filed Critical Dupont Nutrition Biosciences Aps
Publication of PL3322480T3 publication Critical patent/PL3322480T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/181Salivarius

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL16736860T 2015-07-16 2016-07-07 Bakterie Lactobacillus w leczeniu zaburzeń czynności serca PL3322480T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562193539P 2015-07-16 2015-07-16
GBGB1514302.7A GB201514302D0 (en) 2015-07-16 2015-08-12 Lactobacilli for treating cardiac dysfunction
PCT/EP2016/066185 WO2017009188A1 (en) 2015-07-16 2016-07-07 Lactobacilli for treating cardiac dysfunction
EP16736860.4A EP3322480B1 (en) 2015-07-16 2016-07-07 Lactobacilli for treating cardiac dysfunction

Publications (1)

Publication Number Publication Date
PL3322480T3 true PL3322480T3 (pl) 2021-04-19

Family

ID=54200651

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16736860T PL3322480T3 (pl) 2015-07-16 2016-07-07 Bakterie Lactobacillus w leczeniu zaburzeń czynności serca

Country Status (7)

Country Link
US (4) US20180207210A1 (pl)
EP (1) EP3322480B1 (pl)
DK (1) DK3322480T3 (pl)
ES (1) ES2834736T3 (pl)
GB (1) GB201514302D0 (pl)
PL (1) PL3322480T3 (pl)
WO (1) WO2017009188A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2021010160A (es) * 2019-02-22 2021-09-14 Evelo Biosciences Inc Preparaciones de membrana bacteriana.
US20250136924A1 (en) * 2023-10-26 2025-05-01 Gene Guard Detox, Inc. Food grade bacteria and methods for removing glyphosate and other harmful substances

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20030274A1 (es) * 2001-07-26 2003-05-08 Alimentary Health Ltd Cepas de lactobacillus salivarius
EP1608383A1 (en) * 2003-03-31 2005-12-28 Alimentary Health Limited A formulation comprising a bacterial strain
US20110189149A1 (en) * 2008-06-20 2011-08-04 Remy Burcelin New Uses of Lactic Acid Bacteria and Bifidobacteria
EP2808024B1 (en) * 2009-06-19 2019-04-24 DuPont Nutrition Biosciences ApS Bifidobacteria for treating congestive heart failure
CN103189504B (zh) * 2010-06-18 2017-05-24 北卡罗莱纳州立大学 减少炎性反应的具有减少的脂磷壁酸的重组乳杆菌
JP6286434B2 (ja) * 2012-09-20 2018-02-28 プロセラ インコーポレイテッド 肥満および肥満関連疾患の治療のためのプロバイオティクス組成物および方法

Also Published As

Publication number Publication date
US20250262255A1 (en) 2025-08-21
DK3322480T3 (da) 2021-01-04
US20240041953A1 (en) 2024-02-08
WO2017009188A1 (en) 2017-01-19
EP3322480A1 (en) 2018-05-23
US20180207210A1 (en) 2018-07-26
GB201514302D0 (en) 2015-09-23
US20210346439A1 (en) 2021-11-11
ES2834736T3 (es) 2021-06-18
EP3322480B1 (en) 2020-10-14

Similar Documents

Publication Publication Date Title
IL283086A (en) Use of cannabidiol in the treatment of tuberous sclerosis complex
IL279752B (en) Polycyclic compounds and use thereof in the treatment of immune disorders
IL257105A (en) Modified cells and methods of therapy
IL253803B (en) A preparation for the treatment of hypothyroidism
IL260684B (en) Treatment for modulating gut microbiota
PL3157512T3 (pl) Zastosowanie kannabidioli w leczeniu padaczki
PL3265053T3 (pl) Sposoby leczenia skóry
PL3943093T3 (pl) Zastosowanie pasteryzowanej akkermansia do leczenia nowotworu złośliwego
GB2554629B8 (en) Prevention and treatment of microbial infections
HUE061761T2 (hu) Tetrahidropiranil-amino-pirrolopirimidinon felhasználásra BTK-által közvetített zavarok kezelésében
PL3503890T3 (pl) Stosowanie pridopidyny w leczeniu dystonii
EP3334429C0 (en) HYPERPHENYLALANINEMIA AND TREATMENTS THEREFOR
IL258259A (en) Adjunctive therapy with 25-hydroxyvitamin d and articles therefor
PL3773715T3 (pl) Mirikizumab w leczeniu wrzodziejącego zapalenia jelita grubego
IL268210A (en) Use of gaboxadol in the treatment of tinnitus
SG11201607081RA (en) Massage chair and method of driving the same
IL242971B (en) Ventricular far field reduction
PL3236960T3 (pl) Fluralaner do zastosowania w leczeniu demodekozy
EP3728562A4 (en) HEART MICROTISSUE AND ASSOCIATED USES
PT3285787T (pt) Tratamento de infeções bacterianas em aquicultura
GB201404372D0 (en) Assay and treatment
PL3373922T3 (pl) Kompozycje i sposoby do stosowania do leczenia homocystynurii
LT3405197T (lt) Delgocitinibo panaudojimas lėtinės rankų egzemos gydymui
GB201614415D0 (en) Enzymes for the treatment of human enterometabolic dysfunction
IL251840A0 (en) Use of femiroplast in the treatment of severe asthma